90 related articles for article (PubMed ID: 32621544)
1. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study.
Jessurun NT; Vermeulen Windsant A; Mikes O; van Puijenbroek EP; van Marum RJ; Grootens K; Derijks HJ
Br J Clin Pharmacol; 2021 Mar; 87(3):1529-1532. PubMed ID: 32621544
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice.
Jessurun N; van Puijenbroek EP; Otten LS; Mikes O; Vermeulen Windsant A; van Marum RJ; Grootens K; Derijks HJ
Br J Clin Pharmacol; 2017 May; 83(5):1149-1151. PubMed ID: 28133768
[No Abstract] [Full Text] [Related]
4. 10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.
Dalén P; Dahl ML; Bernal Ruiz ML; Nordin J; Bertilsson L
Clin Pharmacol Ther; 1998 Apr; 63(4):444-52. PubMed ID: 9585799
[TBL] [Abstract][Full Text] [Related]
5. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response.
Hodgson K; Tansey K; Dernovsek MZ; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Smith R; Craig IW; Farmer AE; Aitchison KJ; Belsey S; Davis OS; Uher R; McGuffin P
J Psychopharmacol; 2014 Feb; 28(2):133-41. PubMed ID: 24257813
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes.
Yue QY; Zhong ZH; Tybring G; Dalén P; Dahl ML; Bertilsson L; Sjöqvist F
Clin Pharmacol Ther; 1998 Oct; 64(4):384-90. PubMed ID: 9797795
[TBL] [Abstract][Full Text] [Related]
7. Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.
Solai LK; Pollock BG; Mulsant BH; Frye RF; Miller MD; Sweet RA; Kirshner M; Sorisio D; Begley A; Reynolds CF
J Clin Psychopharmacol; 2002 Oct; 22(5):481-6. PubMed ID: 12352271
[TBL] [Abstract][Full Text] [Related]
8. Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: impact of CYP2D6 genotype on the hydroxylation of nortriptyline.
Morita S; Shimoda K; Someya T; Yoshimura Y; Kamijima K; Kato N
J Clin Psychopharmacol; 2000 Apr; 20(2):141-9. PubMed ID: 10770451
[TBL] [Abstract][Full Text] [Related]
9. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
[TBL] [Abstract][Full Text] [Related]
11. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
Dahl ML; Bertilsson L; Nordin C
Psychopharmacology (Berl); 1996 Feb; 123(4):315-9. PubMed ID: 8867869
[TBL] [Abstract][Full Text] [Related]
12. Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians.
Dalén P; Dahl ML; Roh HK; Tybring G; Eichelbaum M; Wilkinson GR; Bertilsson L
Br J Clin Pharmacol; 2003 Jun; 55(6):630-4. PubMed ID: 12814461
[TBL] [Abstract][Full Text] [Related]
13. Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry.
Berm E; Kok R; Hak E; Wilffert B
Pharmacopsychiatry; 2016 Sep; 49(5):186-190. PubMed ID: 27101231
[No Abstract] [Full Text] [Related]
14. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Modeling Analysis Demonstrates the Impact of CYP2C19 and CYP2D6 Genetic Polymorphisms on the Pharmacokinetics of Amitriptyline and Its Metabolite, Nortriptyline.
Koh A; Pak KC; Choi HY; Ryu S; Choi SE; Kim KS; Bae KS; Lim HS
J Clin Pharmacol; 2019 Apr; 59(4):532-540. PubMed ID: 30452773
[TBL] [Abstract][Full Text] [Related]
16. A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects.
Tsukada H; Chen YL; Xiao G; Lennek L; Milanovic SM; Worden M; Polhamus DG; Chiu YY; Hopkins SC; Galluppi GR
Clin Pharmacokinet; 2023 Dec; 62(12):1755-1763. PubMed ID: 37882999
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
Shulman RW; Ozdemir V
Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between nortriptyline and terbinafine.
Van Der Kuy PH; Van Den Heuvel HA; Kempen RW; Vanmolkot LM
Ann Pharmacother; 2002 Nov; 36(11):1712-4. PubMed ID: 12398564
[TBL] [Abstract][Full Text] [Related]
19. Sensitive method for the quantitation of nortriptyline and 10-hydroxynortriptyline in human plasma by capillary gas chromatography with electron-capture detection.
Anliker SL; Hamilton M; Bopp RJ; Goldberg MJ
J Chromatogr; 1992 Jan; 573(1):141-5. PubMed ID: 1564093
[TBL] [Abstract][Full Text] [Related]
20. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
